Exploring Innovations in Muscle Wasting Disease Treatment
In this interview, we engage with David Craig from Sarcomatrix Therapeutics to discuss the development of S-969, a novel...
Moe Alsumidaie
Emervax’s Circular RNA: A New Frontier in Vaccine Development
In this interview, we speak with Peter Weinstein, co-founder of Emervax. The discussion delves into Emervax’s innovative circular RNA...
Navigating Digital Health and Clinical Trials in Saudi Arabia
In this Q&A, we interview Dr. Tamara Sunbul, a digital health clinical trial leader. Dr. Sunbul discusses the regulatory...
Abbott’s Roadmap to Diversifying Clinical Trials
In this interview, Jennifer Jones-McMeans, Ph.D., co-leader of Abbott’s Diversity in Research Office and divisional vice president of global...
FDA Update on ICH E6, E8, QbD and RBM in Clinical Trials
The recent FDA workshop, “Building Quality into the Design and Conduct of Clinical Studies: Integrating Quality by Design (QbD)...
Pioneering the First Lab and Theranostic Platform: A Conversation with NuView CEO, Paul Crowe
NuView Life Sciences is transforming cancer diagnostics and treatment with its pioneering NV-VPAC1™ platform. This first-of-its-kind technology integrates in...
EMA Discusses European Clinical Trial Decline at DTRA
At the 2024 Decentralized Trials & Research Alliance (DTRA) Annual Meeting, Dr. Amir Kalali of the DTRA and Dr....
How Technology Can Address Upcoming Big Pharma Financial Crunch
In this interview, we speak with Jim Corrigan, CEO of YPrime, about the future of clinical trial technologies. The...
Advancing Leukemia Care with Sellas: GPS & SLS009 Insights
We had the opportunity to speak with Dr. Angelos M. Stergiou, MD, Sc.D. h.c., about potential advancements in leukemia...
Transforming Biologic Delivery: An Interview with Surf Bio
In this interview, we speak with Bryan Mazlish, CEO of Surf Bio, about their innovative SnapShotÔ technology. Bryan discusses...